Now that numerous states have legalized recreational marijuana, cannabis has gotten a whole lot more sophisticated. CBD oil, the nonpsychoactive component of the cannabis plant, is said to offer a panacea of positive effects, including relief from pain, anxiety, and depression, not to mention anti-inflammatory properties. Cannabis products have already gained momentum in the supplement and beauty industries, filling the marketplace with elixirs, oils, ingestibles (CBD-infused gummies, caramels, and drops), and wellness lotions.
The birth of CBD can be traced to a government lab in the 1990s. Unlike the better-known marijuana molecule delta-9-tetrahydrocannabinol or THC, CBD doesn’t get users high. But in the late 1990s, scientists at the National Institutes of Health discovered another unusual medicinal benefit. In test tubes, the molecule shielded neurons from oxidative stress, a damaging process common in many neurological disorders, including epilepsy.
Since then, CBD has continued to gain traction. Recently its popularity has surged. Among some neuroscientists, CBD is considered to be the most promising drug that has come out for neuropsychiatric diseases in the last 50 years. Some researchers claim it has a unique combination of safety and effectiveness across a broad range of conditions. CBD has shown promise in treating epilepsy, schizophrenia, post-traumatic stress, and generalized anxiety.
Among consumers in the United States, cannabinoids have been steadily growing in popularity. Thanks to recent cannabis legalization efforts, the U.S. House of Representatives is slated to debate on cannabis’ federal legalization.
As the global CBD industry hurdles toward an impressive $29.91 billion valuation by 2025, a few key players are leading the way to cannabinoids’ continual acceptance, including FAB CBD. Offering a variety of more than 40 products, including oils, gummies, creams, and salves, FAB has left no stone unturned in its quest to make quality CBD attainable for all. Importantly, all of FAB CBD’s products have been third-party tested for efficacy and safety.
“All of our formulations at FAB CBD are driven by science, innovation, and attention to customer needs,” said Founder Josh Delaney. “We do our homework and put time and care into every supplement we create, from the sourcing of ingredients to the manufacture of the products and the customer experience of purchasing and using what they buy from us. We put enormous effort into making sure there is no weak link in the process, ensuring only the best outcomes for our customers.”
One factor that has bolstered the success of FAB CBD since its inception in 2017 is its team’s unrivaled marketing expertise. The group has a background in the wellness supplements market, which has allowed it to contribute to the quick expansion of FAB CBD. They have used their extensive network and advertising prowess to make the powers of CBD accessible to the home consumer. FAB CBD prides itself on being an education-based company, providing blogs and content to help customers understand what they are using and why.
With publicly-traded cannabis powerhouse High Tide Inc. now at the helm of FAB CBD, the burgeoning CBD brand is quickly growing into a national leader, consistently pulling in millions of dollars in EBITDA annually. FAB CBD’s grip on the growing cannabinoid market seems destined to continue as the use of CBD becomes increasingly commonplace around the world.
